INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Open-market saleVerified data

Kaye Mark sold ELV

EVP & CFO · Elevance Health, Inc. · Common Stock

Side
SELL
Value
$724K
Shares
1,660
Price
$436.2
Executed
Oct 22, 2026
Disclosed
Oct 23, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 22 executedOct 23, 2026 disclosed

ELV · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
31/ 100 · ELEVATED
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+11 / 25

    $724K reported value · 5.6% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ELV

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    24
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Open-market sale
    		SELL$174K
    400 sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    24
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Open-market sale
    		SELL$212K
    480 sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    27
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Open-market sale
    		SELL$510K
    1,160 sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    24
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Open-market sale
    		SELL$195K
    440 sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    24
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Open-market sale
    		SELL$71K
    160 sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    27
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Open-market sale
    		SELL$369K
    827 sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    24
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Open-market sale
    		SELL$122K
    273 sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    24
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Open-market sale
    		SELL$105K
    240 sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    24
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Open-market sale
    		SELL$140K
    321 sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    24
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Open-market sale
    		SELL$245K
    560 sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    31
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Open-market sale
    		SELL$758K
    1,720 sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    34
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Open-market sale
    		SELL$1.03M
    2,343 sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    13
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Grant or award
    		A—
    2,627 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    22
    KM
    Kaye MarkEVP & CFO
    ELVElevance Health, Inc.
    Tax withholding
    		F$1.61M
    4,161 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    9
    WM
    Wessling Erin MEVP & Chief Legal Officer
    ELVElevance Health, Inc.
    Tax withholding
    		F$38K
    94 sh
    		Sep 2, 2026Sep 4, 2026
    traded Sep 2, 2026
    		+2dSEC FORM 4

    Evidence

    12
    CR
    Craig Ryan REVP & Chief HR Officer
    ELVElevance Health, Inc.
    Tax withholding
    		F$58K
    144 sh
    		Sep 2, 2026Sep 4, 2026
    traded Sep 2, 2026
    		+2dSEC FORM 4

    Evidence

    12
    WM
    Wessling Erin MEVP & Chief Legal Officer
    ELVElevance Health, Inc.
    Tax withholding
    		F$106K
    255 sh
    		Sep 3, 2026Sep 4, 2026
    traded Sep 3, 2026
    		+1dSEC FORM 4

    Evidence

    21
    CR
    Craig Ryan REVP & Chief HR Officer
    ELVElevance Health, Inc.
    Grant or award
    		A—
    2,976 sh
    		Mar 2, 2026Mar 4, 2026
    traded Mar 2, 2026
    		+2dSEC FORM 4

    Evidence

    21
    WM
    Wessling Erin MEVP & Chief Legal Officer
    ELVElevance Health, Inc.
    Grant or award
    		A—
    2,976 sh
    		Mar 2, 2026Mar 4, 2026
    traded Mar 2, 2026
    		+2dSEC FORM 4

    Evidence

    16
    WM
    Wessling Erin MEVP & Chief Legal Officer
    ELVElevance Health, Inc.
    Tax withholding
    		F$118K
    417 sh
    		Mar 3, 2026Mar 4, 2026
    traded Mar 3, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001748691-26-000008
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 22, 2026
    Published
    Oct 23, 2026
    Ingested by INSIDER
    Nov 5, 02:09 UTC
    Last re-read
    Nov 5, 02:09 UTC

    Extracted facts

    Filer
    Kaye Mark
    Role
    EVP & CFO
    Transaction
    Open-market saleAs filed: “S”
    Asset
    Elevance Health, Inc.
    Ticker
    ELV
    Shares
    1,660
    Price per share
    $436.2
    Value
    $724,092
    Execution date (reported)
    Oct 22, 2026
    Owned after transaction
    28.1K shares
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 1,660
    • Price: $436.2

    = $724,092

    What this establishes

    Kaye Mark filed this Form 4 reporting a open-market sale of ELV on Oct 22, 2026. It became public on Oct 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EVP & CFO
    Kaye Markcik:0001748691
    Issuer
    Elevance Health, Inc.cik:0001156039

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.